Oxidants/antioxidants in idiopathic pulmonary fibrosis.
作者信息
MacNee W, Rahman I
机构信息
Department of Medicine, Royal Infirmary, Edinburgh, UK.
出版信息
Thorax. 1995 Sep;50 Suppl 1(Suppl 1):S53-8. doi: 10.1136/thx.50.suppl_1.s53.
Abstract
摘要
相似文献
1
Oxidants/antioxidants in idiopathic pulmonary fibrosis.特发性肺纤维化中的氧化剂/抗氧化剂
Thorax. 1995 Sep;50 Suppl 1(Suppl 1):S53-8. doi: 10.1136/thx.50.suppl_1.s53.
2
The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis.口服N-乙酰半胱氨酸对特发性肺纤维化患者肺组织谷胱甘肽水平的影响。
Eur Respir J. 1994 Mar;7(3):431-6. doi: 10.1183/09031936.94.07030431.
3
Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals.肺纤维化患者和正常人的静脉注射N-乙酰半胱氨酸与肺谷胱甘肽
Am J Respir Crit Care Med. 1995 Sep;152(3):1055-60. doi: 10.1164/ajrccm.152.3.7663783.
4
Antioxidant therapy for idiopathic pulmonary fibrosis.特发性肺纤维化的抗氧化治疗
N Engl J Med. 2005 Nov 24;353(21):2285-7. doi: 10.1056/NEJMe058210.
5
Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled.特发性肺纤维化的抗氧化治疗：燃起希望。
Eur Respir J. 2006 Apr;27(4):664-6. doi: 10.1183/09031936.06.00010006.
6
Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.由纤维化肺泡炎患者的天然支气管肺泡灌洗液引发的成纤维细胞趋化反应。
Thorax. 1993 Jul;48(7):736-42. doi: 10.1136/thx.48.7.736.
7
[The effect of oral N-acetylcysteine on glutathione concentration in bronchoalveolar lavage of patients with fibrosing lung diseases].[口服N-乙酰半胱氨酸对肺纤维化疾病患者支气管肺泡灌洗中谷胱甘肽浓度的影响]
Med Klin (Munich). 1991 Jun 15;86(6):279-83.
8
Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.环磷酰胺与低剂量泼尼松龙治疗特发性肺纤维化和纤维化非特异性间质性肺炎
Eur Respir J. 2005 Mar;25(3):528-33. doi: 10.1183/09031936.05.00071004.
9
Oxidant-protease interaction in the lung. Prospects for antioxidant therapy.
Chest. 1996 Dec;110(6 Suppl):267S-272S. doi: 10.1378/chest.110.6_supplement.267s.
10
Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis.
Lancet. 1991 Jul 27;338(8761):215-6. doi: 10.1016/0140-6736(91)90350-x.
引用本文的文献
1
HIP/PAP protects against bleomycin-induced lung injury and inflammation and subsequent fibrosis in mice.HIP/PAP 可预防博来霉素诱导的小鼠肺损伤、炎症和随后的纤维化。
J Cell Mol Med. 2020 Jun;24(12):6804-6821. doi: 10.1111/jcmm.15334. Epub 2020 Apr 30.
2
Lung extracellular matrix and redox regulation.肺细胞外基质与氧化还原调节。
Redox Biol. 2016 Aug;8:305-15. doi: 10.1016/j.redox.2016.02.005. Epub 2016 Feb 18.
3
Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.间质性肺疾病患者血浆中蛋白质酪氨酸残基的氧化修饰增加。
Am J Respir Crit Care Med. 2016 Apr 15;193(8):861-8. doi: 10.1164/rccm.201505-0992OC.
4
Lipidomics revealed idiopathic pulmonary fibrosis-induced hepatic lipid disorders corrected with treatment of baicalin in a murine model.脂质组学揭示了特发性肺纤维化引起的肝脂代谢紊乱，而黄芩苷治疗可纠正这一紊乱。
AAPS J. 2015 May;17(3):711-22. doi: 10.1208/s12248-014-9714-4. Epub 2015 Mar 12.
5
Preventive effect of chrysin on bleomycin-induced lung fibrosis in rats.白杨素对博莱霉素诱导的大鼠肺纤维化的预防作用。
Inflammation. 2014 Dec;37(6):2116-24. doi: 10.1007/s10753-014-9946-6.
6
Novel therapeutic approaches for pulmonary fibrosis.新型肺纤维化治疗方法。
Br J Pharmacol. 2011 May;163(1):141-72. doi: 10.1111/j.1476-5381.2011.01247.x.
7
Extracellular superoxide dismutase in pulmonary fibrosis.肺纤维化中的细胞外超氧化物歧化酶
Antioxid Redox Signal. 2008 Feb;10(2):343-54. doi: 10.1089/ars.2007.1908.
8
Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.氧化应激、纤溶酶原激活物抑制剂1与肺纤维化
Antioxid Redox Signal. 2008 Feb;10(2):303-19. doi: 10.1089/ars.2007.1903.
9
Analysis of carbonylated proteins in bronchoalveolar lavage of patients with diffuse lung diseases.
Lung. 2007 May-Jun;185(3):139-44. doi: 10.1007/s00408-007-9001-6. Epub 2007 May 12.
10
Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.长期施用一种小分子催化金属卟啉抗氧化剂AEOL 10150可保护肺部免受辐射诱导的损伤。
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):573-80. doi: 10.1016/j.ijrobp.2006.09.053.
本文引用的文献
1
Elevated serum superoxide dismutase levels correlate with disease severity and neutrophil degranulation in idiopathic pulmonary fibrosis.
Clin Sci (Lond). 1993 Sep;85(3):353-9. doi: 10.1042/cs0850353.
2
The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom.英国三个地区隐源性纤维性肺泡炎的管理
Eur Respir J. 1993 Jun;6(6):891-3.
3
Effect of cigarette smoke and its condensates on alveolar epithelial cell injury in vitro.香烟烟雾及其冷凝物对体外肺泡上皮细胞损伤的影响。
Am J Physiol. 1994 Jan;266(1 Pt 1):L92-100. doi: 10.1152/ajplung.1994.266.1.L92.
4
Age, sex, cigarette smoking and indices of free radical activity in healthy humans.健康人群的年龄、性别、吸烟情况及自由基活性指标
Eur J Med. 1993 Apr;2(4):205-8.
5
Cytokines and pulmonary fibrosis.细胞因子与肺纤维化
Thorax. 1993 Sep;48(9):931-5. doi: 10.1136/thx.48.9.931.
6
Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung.细胞因子。2. 细胞因子与肺部炎症：中性粒细胞募集至肺部的机制
Thorax. 1993 Jul;48(7):765-9. doi: 10.1136/thx.48.7.765.
7
Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue.N-乙酰半胱氨酸对血浆、支气管肺泡灌洗液和肺组织中硫醇浓度的影响。
Thorax. 1994 Jul;49(7):670-5. doi: 10.1136/thx.49.7.670.
8
The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis.口服N-乙酰半胱氨酸对特发性肺纤维化患者肺组织谷胱甘肽水平的影响。
Eur Respir J. 1994 Mar;7(3):431-6. doi: 10.1183/09031936.94.07030431.
9
An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro.谷胱甘肽在香烟烟雾体内外诱导上皮通透性增加中作用的研究
Am J Respir Crit Care Med. 1994 Jun;149(6):1518-25. doi: 10.1164/ajrccm.149.6.8004308.
10
New strategies for treatment of pulmonary fibrosis.治疗肺纤维化的新策略。
Thorax. 1995 Apr;50(4):415-21. doi: 10.1136/thx.50.4.415.
Zotero 插件